Federation des caisses Desjardins du Quebec’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.3K | Buy |
17,300
+2,000
| +13% | +$6.86K | ﹤0.01% | 1507 |
|
|
2025
Q1 | $34.1K | Sell |
15,300
-100
| -0.6% | -$223 | ﹤0.01% | 1560 |
|
|
2024
Q4 | $45.1K | Buy |
15,400
+3,650
| +31% | +$10.7K | ﹤0.01% | 1446 |
|
|
2024
Q3 | $30.6K | Buy |
11,750
+1,550
| +15% | +$4.03K | ﹤0.01% | 1538 |
|
|
2024
Q2 | $30.2K | Buy |
10,200
+1,450
| +17% | +$4.29K | ﹤0.01% | 1502 |
|
|
2024
Q1 | $39.6K | Buy |
8,750
+750
| +9% | +$3.4K | ﹤0.01% | 1471 |
|
|
2023
Q4 | $45.7K | Buy |
8,000
+2,000
| +33% | +$11.4K | ﹤0.01% | 1341 |
|
|
2023
Q3 | $27.6K | Buy |
6,000
+500
| +9% | +$2.3K | ﹤0.01% | 1483 |
|
|
2023
Q2 | $35.5K | Hold |
5,500
| – | – | ﹤0.01% | 1428 |
|
|
2023
Q1 | $41.5K | Hold |
5,500
| – | – | ﹤0.01% | 1385 |
|
|
2022
Q4 | $55.7K | Sell |
5,500
-1,000
| -15% | -$10.1K | ﹤0.01% | 1419 |
|
|
2022
Q3 | $64.3K | Buy |
6,500
+200
| +3% | +$1.98K | ﹤0.01% | 1446 |
|
|
2022
Q2 | $67.1K | Buy |
6,300
+800
| +15% | +$8.52K | ﹤0.01% | 1452 |
|
|
2022
Q1 | $53.6K | Buy |
5,500
+1,475
| +37% | +$14.4K | ﹤0.01% | 1566 |
|
|
2021
Q4 | $57.6K | Sell |
4,025
-750
| -16% | -$10.7K | ﹤0.01% | 1556 |
|
|
2021
Q3 | $95.7K | Buy |
4,775
+2,350
| +97% | +$47.1K | ﹤0.01% | 1419 |
|
|
2021
Q2 | $53.4K | Buy |
+2,425
| New | +$53.4K | ﹤0.01% | 1593 |
|